Press Release

Electrophysiology (EP) Devices Market to Reach USD24 Billion by 2030 Due to Rising Cases of Cardiovascular Diseases

The Global Electrophysiology (EP) Devices Market size was valued at around USD12 Billion in 2024 and is projected to reach USD24 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 12% during the forecast period, i.e. 2025-30, cites MarkNtel Advisors in the recent research report. Global EP devices market growth is anticipated to be sizeable because of the growth in cardiovascular sicknesses, demographic shifts, and a growth in healthcare investments. Cardiovascular diseases, particularly cardiac arrhythmias, are increasingly being pronounced these days due to horrific lifestyles and awful consumption conduct of alcohol and tobacco.

Additionally, the stroke burden has dramatically increased globally; according to the WHO, the incidence of stroke increased by 70% between 1990 and 2019, with an increase in the death rate of 43% due to strokes. These dire trends highlight the urgent need for more sophisticated medical equipment, including electrophysiology devices. Added demand comes from further demographic changes brought about by growing aged populations from declining global fertility rates, which the World Bank currently reports at 2.26 in 2022. An aging population is inherently prone to heart disease, thus necessitating a lifelong need for electrophysiology devices globally.

Simultaneously, healthcare modernization initiatives are accelerating market growth. Global health expenditure has been going up noticeably after the pandemic because it is about upgrading and expanding the healthcare infrastructures of countries. North America, being the leader in the EP devices market, exemplifies this new trend. According to the Centers for Medicare and Medicaid Services (CMS), the biggest market in this region spent USD 4.1 trillion on health care in 2020 and was expected to spend around USD 4.8 trillion by 2023, or around USD 14,423 per person. The unfolding of these developments would provide robust growth to the electrophysiology devices market globally over the foreseeable future, further states the research report, “Global Electrophysiology Devices Market Analysis, 2025.”

Global Electrophysiology (EP) Devices Market Segmentation Analysis

Implantable Segment Holds the Largest Market Share

Based on the modality, the market is further bifurcated into, implantable and external. The implantable segment leads the market in the global electrophysiology devices market in 2024 with over 50% market share. This is due to their essential role in the management of cardiovascular disease and continuous technological advancements. These types of EP devices are highly effective for monitoring an uneven heartbeat. Moreover, they also help in avoiding a number of strokes by incorporating devices such as defibrillators and pacemakers. Such equipment further facilitates the detection and treatment of diseases like bradycardia, heart failure, and arrhythmia. They remain one of the first choices among all healthcare service providers across the world. In terms of advanced technologies, these miniaturization and wireless connection technologies have contributed a lot by facilitating remote cardiac monitoring and providing greater comfort to patients and their doctors. This has cemented the dominance of implantable devices and ensured that it will remain the leading segment in the market for the forecasted period.

North America Dominates the Global Market

North America dominates the Global Electrophysiology (EP) Devices Market in 2024 with more than 45% market share, characterized by strong healthcare expenditure, prevalence of heart diseases, and an aging demographic. The largest contributor to this dominance is the USA, where healthcare expenditure goes up to nearly USD 4.8 trillion in 2023. Cardiovascular diseases are still the biggest challenge facing the country, as heart disease constitutes 20% of all deaths. According to the CDC report, in 2022 alone, 702,880 Americans died from heart disease, and every year around 805,000 had a heart attack.

The declining fertility rate in the region is leading to an aging demographic, which again gives rise to heart-related disorders. The unfolding of these scenarios would drive the demand for EP devices in the region, leading to market growth worldwide.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including Abbott Laboratories, Acutus Medical, Siemens, Nihon Kohden Corporation, Biosense Webster, Boston Scientific Corporation, GE Healthcare, Medtronic, Philips, Biotronik, Microport Scientific Corporation, AliveCor, Bittium Corporation, Stereotaxis, Japan Lifeline, and Others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across various regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?